专利号:US-10906888-B2 优先权日:2016-07-14 标 题:Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme 发明人:CASIMIRO-GARCIA AGUSTIN; STROHBACH JOSEPH WALTER; HEPWORTH DAVID; LOVERING FRANK ELDRIDGE; CHOI CHULHO; ALLAIS CHRISTOPHE PHILIPPE; WRIGHT STEPHEN WAYNE 权利人:PFIZER 摘要:Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:US-10308615-B2 优先权日:2015-05-29 标 题:Heterocyclic compounds as inhibitors of Vanin-1 enzyme 发明人:CASIMIRO-GARCIA AGUSTIN; CONDON JEFFREY SCOTT; FLICK ANDREW CHRISTOPHER; GOPALSAMY ARIAMALA; KIRINCICH STEVEN J; MATHIAS JOHN PAUL; STROBACH JOSEPH WALTER; XIANG JASON SHAOYUN; XING LI HUANG; WANG XIAOLUN 权利人:PFIZER 摘要:Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:US-2018230127-A1 优先权日:2015-08-13 标题 :Bicyclic-Fused Heteroaryl Or Aryl Compounds 发明人:ANDERSON DAVID RANDOLPH; CURRAN KEVIN JOSEPH; GAVRIN LORI KRIM; GOLDBERG JOEL ADAM; LEE ARTHUR; LOWE MICHAEL DENNIS; PATNY AKSHAY; PIERCE BETSY SUSAN; SAIAH EDDINE; TRZUPEK JOHN DAVID 权利人:PFIZER 摘要:Compounds, tautomers and pharmaceutically acceptable salts of the compounds of Formula (Ia) are disclosed which are inhibitors of Interleukin-1 receptor associated kinase (IRAK4). Methods of treatment, methods of synthesis, and intermediates are also disclosed as defined in the specification.
专利号:US-10316018-B2 优先权日:2015-08-27 标题 :Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators 发明人:LEE KATHERINE LIN; ALLAIS CHRISTOPHE PHILIPPE; DEHNHARDT CHRISTOPH MARTIN; GAVRIN LORI KRIM; HAN SEUNGIL; HEPWORTH DAVID; LEE ARTHUR; LOVERING FRANK ELDRIDGE; MATHIAS JOHN PAUL; OWEN DAFYDD RHYS; PAPAIOANNOU NIKOLAOS; SAIAH EDDINE; STROHBACH JOSEPH WALTER; TRZUPEK JOHN DAVID; WRIGHT STEPHEN WAYNE; ZAPF CHRISTOPH WOLFGANG 权利人:PFIZER 摘要:Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:CN-114773262-B 优先权日:2022-05-19 标题:Synthesis method of methyl 2-cyano-4-pyridinecarboxylate
专利号:US-2021290651-A1 优先权日:2020-03-20 标 题:Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
1: Zhong T, Huang K, Han L, Pang W, Xia Y, Qu S, Yu G, Chen Y, Fan H. Characterizing Pharmacokinetic Variability of Topiroxostat in Chinese Population: Insights from a Phase I Randomized Clinical Trial. Curr Drug Metab. 2024 Dec 16. doi: 10.2174/0113892002348045241210071452. Epub ahead of print. 72(11):73-79. doi: 10.59556/japi.72.0724. 230(Pt 2):116596. doi: 10.1016/j.bcp.2024.116596. Epub 2024 Oct 29. 6(11):100896. doi: 10.1016/j.xkme.2024.100896. 5: Rana R, Sharma A, Kumar N, Khanna A, Jyoti, Dhir M, Gulati HK, Singh JV, Bedi PMS. A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics. Mol Divers. 2024 Aug 20. doi: 10.1007/s11030-024-10962-1. Epub ahead of print. 982:176915. doi: 10.1016/j.ejphar.2024.176915. Epub 2024 Aug 16. 275(Pt 1):133450. doi: 10.1016/j.ijbiomac.2024.133450. Epub 2024 Jun 27.
合成参考文献
参考文献:10.1272/jnms.75.2 摘要:Okamoto K, Nishino T. Crystal structures of mammalian xanthine oxidoreductase bound with various inhibitors: allopurinol, febuxostat, and FYX-051. J Nippon Med Sch. 2008 Feb;75(1):2–3. doi: 10.1272/jnms.75.2. 参考文献:10.1007/s10157-014-0989-7 摘要:Ohya M, Shigematsu T. A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients. Clinical and Experimental Nephrology. 2014 May 29;18(6):835–6. doi: 10.1007/s10157-014-0989-7. 参考文献:10.1007/164_2020_383 摘要:Vickneson K, George J. Xanthine Oxidoreductase Inhibitors. Handb Exp Pharmacol. 2021;264():205–28. doi: 10.1007/164_2020_383.